https://mc06.manuscriptcentral.com/cjpp-pubs Sprague-Dawley rats were used in this study. Cardiac ischemia/reperfusion (I/R) was induced by 30-min occlusion and 3-h reperfusion of left anterior descending coronary artery. RPerC were performed by 5-min occlusion of right femoral artery followed by 5-min reperfusion for three times during cardiac ischemia. Hemodynamics, left ventricular function, arrhythmia, and infarct area were measured. Protein expression levels of eNOS, iNOS, PKCε, and PKCδ in myocardium were assayed. During I/R, systolic artery pressure and left ventricular function were decreased, infarct area was increased, and arrhythmia score was increased (P<0.05). However, changes of the above parameters were significantly attenuated in RPerC-treated rats compared with control rats (P<0.05). The cardiac protective effects of RPerC were prevented by naloxone or glibenclamide. Also, RPerC increased the protein expression levels of eNOS, iNOS, PKCε, and PKCδ in myocardium compared with control rats. These effects were blocked by naloxone, an opioid receptor antagonist, and glibenclamide, an ATP-sensitive K + channel blocker (K ATP ). In summary, this study suggests that RPerC protects heart against I/R injury through activation of opioid receptors and NO-PKC-K ATP channel signaling pathways.
Limb remote ischemia per-conditioning protects heart against ischemia/reperfusion injury through opioid system in rats Li Zhang 1,2* D r a f t Abstract： ： ： ：Remote ischemia per-conditioning (RPerC) has been demonstrated to have cardiac protection, but the underlying mechanism remains unclear. This study aimed to investigate the mechanism underlying cardiac protection of RPerC. Adult male Sprague-Dawley rats were used in this study. Cardiac ischemia/reperfusion (I/R) was induced by 30-min occlusion and 3-h reperfusion of left anterior descending coronary artery. RPerC were performed by 5-min occlusion of right femoral artery followed by 5-min reperfusion for three times during cardiac ischemia. Hemodynamics, left ventricular function, arrhythmia, and infarct area were measured. Protein expression levels of eNOS, iNOS, PKCε, and PKCδ in myocardium were assayed. During I/R, systolic artery pressure and left ventricular function were decreased, infarct area was increased, and arrhythmia score was increased (P<0.05). However, changes of the above parameters were significantly attenuated in RPerC-treated rats compared with control rats (P<0.05). The cardiac protective effects of RPerC were prevented by naloxone or glibenclamide. Also, RPerC increased the protein expression levels of D r a f t
Introduction
Coronary heart disease (CHD) is the leading cause of death all over the world. The major consequence of CHD is acute ischemia/reperfusion (I/R) injury in cardiac myocardium. Thus, development of innovative strategies to protect myocardium against I/R injury is necessary for patients with CHD.
Ischemic pre-conditioning (IPC) protects heart from cardiac tissue injury during prolonged ischemia through applying a short period of sub-lethal ischemia conducted in the heart (Murry et al. 1986 ). Ischemic post-conditioning (PostC), a modified schedule of reperfusion，also protects the heart from intermittent restoration of blood flow after a prolonged episode of ischemia (Zhao et al. 2003) . Myocardial protection against I/R can also be induced by ischemia in organs and tissues which are distant from the heart, a process called remote ischemic pre-conditioning (RIPC) (Aimo et al. 2015) . RIPC is induced by a brief period of ischemia in distant organs such as limb (Birnbaum et al. 1997) , kidney (Pell et al. 1998 ), or mesentery (Gho et al. 1996) to reduce myocardial infarction and protect against I/R injury in porcine, rabbit, rat, as well as human (Kharbanda et al. 2002) . RIPC is more attractive than traditional cardiac pre-conditioning or post-conditioning for its simple application in clinical practice and being the same efficiency as IPC or PostC. Like traditional cardiac conditioning, RIPC can be used before I/R. Also，it has been shown that several short periods of limb ischemia administered at the time of myocardial ischemia, termed as remote ischemia per-conditioning (RPerC), produce significant cardiac protection in pigs (Schmidt et al. 2007) . Recently, Zhu et al compared three remote conditioning strategies on the cardiac protection in rats and found that RPerC produced more prevention of arrhythmia during I/R than that produced by RIPC or RIPostC (Zhu et al. 2013) . The mechanism, however, for this phenomenon was not fully elucidated.
The opioid receptors including µ, δ, and κ subtypes and their endogenous ligands play important role in cardiac protection (Headrick et al. 2015) . Many studies demonstrated that opioid receptors play important roles in the cardiac protection during IPC and PostC (Fraessdorf et al. 2015; Liu 2007; Lu et al. 2011) . Also, opioid receptors are involved in the cardiac protection of RIPC (Rentoukas et al. 2010; Surendra et al. 2013; Wever et al. 2013; Wong et al. 2012) . In this study, we determine whether opioid receptors are involved in the cardiac protection of RPerC.
The ATP-sensitive K + channels (K ATP ) are activated by low concentration of intracellular ATP and are important K + channels that regulate myocardial function.
K ATP channels are categorized into membrane K ATP channels and mitochondrion K ATP channels (mitoK ATP ). K ATP , especially mitoK ATP channels, have been demonstrated to be involved in short-term cardiac protection such as ischemia pre-conditioning. In this regard, opening of the mitoK ATP channels by diazoxide induces cardiac protection in nitric oxide (NO)-dependent manner (Wang et al. 2001b ). Furthermore, Rakhit et al reported that the exogenous NO donor induces an early IPC through a cGMP-dependent mechanism and a delayed IPC by a cGMP-independent mechanism, which is mediated by activation of PKC and mitoK ATP channels (Rakhit et al. 2000) .
Thus, the cardiac protection of ischemia pre-conditioning is related with K ATP ，NO, and PKC. The aim of present study is to determine if RPerC protects heart against I/R injury through activation of opioid receptors via NO-PKC-mitoK ATP signaling pathway. Adult male Sprague-Dawley rats (250-280g in body weight) were purchased from the experimental animal center of Hebei Medical University. These rats were divided randomly into five groups: control group, pre-conditioning group, per-conditioning group, naloxone group, and glibenclamide group. All rats were housed at room temperature with a natural light-dark cycle and had free access to standard rodent diet and tap water.
Materials and methods

Animals
Hemodynamics and left ventricular function measurement
The rats were anesthetized with urethane (1g.kg -1 , i.p.). After the trachea being cannulated, the rats were ventilated mechanically through rodent respirator (1.0~1.5 ml/100 g, 60~120 strokes/min, model 680A, Harvard Apparatus, Holliston, MA). The blood pressure (BP) was monitored through a pressure transducer with a tubing cannulated into the left femoral artery. The BP signals were fed into a PowerLab data acquisition system (AD Instrument, Australia). The right femoral artery was isolated for I/R conditioning and right femoral vein was cannulated for administration of drugs.
A cannula was placed into the left cardiacventricle through the right carotid artery to record left ventricular systolic pressure (LVSP). The maximal rate of rise of left ventricular systolic pressure (dp/dt max ) and the maximal rate of decline of left ventricular systolic pressure (dp/dt min ) were recorded by differentiating LVSP. LVSP, dp/dt max and dp/dt min were used to assess the function of left ventricle. Rectal temperature was measured and kept at 37℃by using a servo-controlled heat blanket.
Needle electrode was inserted subcutaneously in the legs and the standard lead II electrocardiography (ECG) was recorded throughout the experiment. The heart rate D r a f t 6 (HR) was calculated from ECG signal.
Induction of myocardial I/R
Myocardial ischemia was induced as described previously (Zhou et al. 2015) . In brief, after thoracotomy and pericardiotomy, a thin silk suture (6.0 metric) was placed superficially into the myocardium around the left anterior descending (LAD) coronary artery 2 mm proximal from its origin in the atrio-ventricular sulcus. The suture was passed through small diameter tubing to forma snare, which was used to occlude the LAD coronary artery when it was tightened. The presence of myocardial ischemia was confirmed by elevation of the S-T segment in ECG and an immediate fall in blood pressure of 15-30mmHg. For reperfusion, the snare was released, and reperfusion was visually confirmed by epicardial blushing, restoration of S-T segment in ECG gradually returned to the baseline level. A total of 30-min ischemia and 3-h reperfusion was performed. The changes of hemodynamics, left ventricular function and cardiac arrhythmia were recorded during I/R. The arrhythmia score was used to evaluate the degree of arrhythmia (Johnston et al. 1983; Walker et al. 1988 ).
Assessment of myocardialinfarction
At the end of reperfusion, the heart was removed quickly and frozen at -20°C.
The frozen heart was cut into 1.5-mm thin slices, which were perpendicular to the septum from the apex to the base. The myocardial slices were stained as described previously (Vivaldi et al. 1985) . In brief, after 3-h reperfusion, 500 IU heparin was administered through the jugular vein to remove any clot in the heart. The LAD coronary artery was re-occluded, and 2 ml of 1.5% Evans Blue (Sigma, USA) was injected through the jugular vein to distinguish the non-ischemic area from area at risk (AAR). The heart was then excised, and the left ventricle was cut transversely into slices at 1-mm thickness and incubated at 37℃ with TTC (triphenyltetrazolium D r a f t chloride; SD Fine Chemicals, Mumbai, India) solution (1%inphosphatebuffer, pH 7.4) for 30min. In the presence of dehydrogenase enzymes in the viable myocytes, NADH reacts with TTC to stain deep red while infarcted myocardium remains pale owing to the absence of dehydrogenases. The slices were fixed in 10% formalin for 6h to obtain 3 colors: blue (non-ischemic area), deep and pale red (AAR as a whole), and unstained pale, representing the infarcted area (IA). The slices were sandwiched between 2 transparent slides and captured by using a scanner. The images were saved and analyzed in a blinded manner by computerized planimetry. Infarct size was expressed as the percentage of IA relative to AAR.
Performance of pre-conditioning and per-conditioning
RIPC was achieved by 5-min occlusion of right femoral artery followed by 5-min reperfusion and the occlusion-reperfusion was repeated for three times before LAD coronary artery occlusion. RPerC was performed during myocardial ischemia and before reperfusion. The femoral artery was exposed in the hind limb muscle where it joins the abdomen and isolated from the nerve and tissue in the pelvic region distal to any branch and occluded with a clip. During the ischemic period, the skin of the leg became purple and the temperature decreased. Reperfusionwas performed by removing the clip and was confirmed when the skin color returned to rose color and temperature increased to the level before ischemia.
Western blot assay
Western blotting was performed as described previously (Xi et al. 2002 
Research protocols
I. Rats in control group were subjected to 30-min ischemia (occlusion of LAD coronary artery) followed by 3-h reperfusion (re-opening the LAD coronary artery).
II. Rats in pre-conditioning group were subjected to remote pre-conditioning procedure: 5-min femoral artery occlusion followed by 1-min re-opening of the artery, which was repeated for three times before LAD coronary artery occlusion.
III. Rats in per-conditioninggroup were subjected to remote per-conditioning procedure: 5-min femoral artery occlusion followed by 1-min re-opening of the artery, which was repeated for three times during LAD coronary artery occlusion.
IV. Rats in naloxone group were received the same treatment as per-conditioning procedure and an injection of naloxone (1.0 mg. kg -1 , Sigma), an antagonist of opioid receptors, 5 min before per-conditioning procedure.
V. Rats in glibenclamide group were received the same treatment as per-conditioning procedure and an injection of glibenclamide (1.0 mg.kg -1 , Sigma), an antagonist of K ATP channels, 5 min before per-conditioning procedure.
Statistics analysis
D r a f t
All data were expressed as mean ± SEM. Differences in infarct sizes, biochemical values, and hemodynamics were compared by one-way ANOVA followed by Tukey-Krame post hoc test for multiple comparisons. The comparison between same groups was made by student t test. Differences were considered significant at P values less than 0.05.
Results
Effect of RPerC on hemodynamics
The baseline systolic artery pressure (SAP), diastolic artery pressure (DAP) and heart rate (HR) showed no differences among groups. Cardiac ischemia decreased SAP significantly (P<0.05-0.01, Table1). However, pre-conditioning procedure attenuated the depressor effect induced by ischemia. In the following reperfusion phase, SAP still remained at lower level. Pre-conditioning procedure and per-conditioning procedure restored the SAP to baseline level from I/R-induced depressor response (P<0.05-0.01). After 3-h reperfusion, SAP was significantly higher in pre-conditioning rats than in control rats (P<0.05, Table 1 ). DAP was not changed during whole process of I/R in all groups (P>0.05, Table 2 ).
There was no significant difference of HR during ischemia among all groups (P>0.05). During reperfusion phase, HR was significantly decreased in control, naloxone, and glibenclamide rats compared with pre-conditioning and per-conditioning rats, respectively (P<0.05, Table3).
Effect of RPerC on left ventricular function
The parameters of left ventricular function were similar at basal condition among groups (P>0.05). Ischemia procedure caused significant decreases in LVSP, dp/dt max D r a f t and dp/dt min . Per-conditioning or pre-conditioning treatment significantly attenuated ischemia-induced reduction of LVSP, dp/dt max and dp/dt min . However, naloxone or glibenclamide injection eliminated the effects of per-conditioning and preconditioning treatment on these parameters. During reperfusion phase, LVSP, dp/dt max and dp/dt min were partly recovered gradually. The degree of recovery for LVSP, dp/dt max and dp/dt min was higher in per-conditioning and pre-conditioning groups than those in control, naloxone, or glibenclamide groups (P<0.05-0.01). In addition, the left ventricular function during I/R did not differ between control, naloxone or glibenclamide-treated rats (P>0.05, Figure 1 ).
Effect of RPerC on cardiac infarct size
After cardiacI/R, the ratios of infarct area to risk area were 42.0, 12.2, 11.5, 31.4
and 45.6% in control, pre-conditioning, per-conditioning, naloxone and glibenclamide rats, respectively. The ratio in per-conditioning rats was significantly smaller than in control, naloxone, or glibenclamide rats (P<0.05-0.01), but did not differ compared with pre-conditioning rats (P>0.05, Figure 2 ).
Effect of RPerC on ventricular arrhythmia
Arrhythmia including ventricular premature heartbeat, tachycardia, and fibrillation was induced by I/R procedure. The arrhythmia scores were 2.9, 1.5, 1.4, 2.1, and 3.0 in control, pre-conditioning, per-conditioning, naloxone and glibenclamide rats during ischemia and 4.1, 1.6, 2.0, 2.8, and 3.4 during reperfusion.
The scores in pre-conditioningrats were significantly smaller than those in control, naloxone, and glibenclamide rats (P<0.05, Figure 3 ), but did not differ compared with per-conditioning rats during I/R (P>0.05, Figure 3 ). These results suggest that per-conditioning and pre-conditioning protected heart against I/R injury, and the protective effect was eliminated by pretreatment with naloxone or glibenclamide.
D r a f t
Effect of RPerC on expression of NOS in myocardium
Compared with controlrats, the expression of iNOS and eNOS in per-conditioning rats was increased significantly (P<0.01). The expression of iNOS was higher in naloxone or glibenclamide rats than in control rats, but was lower than in per-conditioning rats (P<0.05). The expression levels of eNOS did not differ among control, naloxone, or glibenclamide rats (P>0.05, Figure4) .
Effect of RPerCon expression of PKC in myocardium
Compared with control rat, PKCε and PKCδ expression levels in per-conditioning rats were increased significantly (P<0.01). The expression of PKCε was similar among control, naloxone, or glibenclamide rats (P>0.05). The expression of PKCδ in naloxone rats was increased compared with control rats, but decreased compared with per-conditioning rats (P<0.05, Figure 5 ).
Discussion
In the present study, we examined the cardiac protective effect of RPerC during I/R. We also compared the protective effect of RPerC with that generated by RIPC.
We found that RPerC, like RIPC, induced cardiac protection against I/R injury Naloxone，a specific antagonist for opioid receptors，antagonizes the effect generated by both exogenous and endogenous opioids. Opioid receptors are divided into four sub-types: µ, δ, κ, and σ subtypes. The µ, δ, and κ opioid subunits are distributed in human and rodent heart tissues. Only δ and κ subunits are found in adult rat heart. It has been shown that cardiac protection of RIPC isrelated to opioid signaling pathways (Patel et al. 2002) . Furthermore, cardiac protection of RIPC is closely related to δ opioid receptor, but not µ-or κ-opioid receptors (Schultz et al. 1998) . Previous study has shown that κ-opioid receptors mediate the improvement of ischemia-induced infarction and arrhythmia through PKC and K ATP pathways , while δ-opioid receptors are involved in improvement of ischemia-induced infarction (Wang et al. 2001a) . It has been shown that K ATP channels mediate the cardiac protection of δ-receptor. Activation of K ATP channels inhibits Ca 2+ influx to reduce Ca 2+ overload in myocardium and leads to an alleviation of myocardium injury (Schultz et al. 1997 ).
However, whether opioid receptor system is involved in the cardiac protection of RPerC is not previously known. In this study, we found that the cardiac protection of RPerC was abolished by naloxone, suggesting that the opioid receptorsare involved in the cardiac protection of RPerC. However, we did not identify the receptor subtypes, which are involved in RIPC or RPerC. Thus, further studies are needed to identify the subtype of opioid receptors involved in cardiac protection by RIPC or RPerC (Maslov et al. 2016 ).
K ATP channels play an important role in the cardiac protection under pathological situations. It has been reported that K ATP channel openers suppress cardiac arrhythmia after ischemia reperfusion (Watanabe et al. 2011) . Also, overexpression of K ATP subunit increases resistance against cardiac ischemia (Du et al. 2006) . Previous D r a f t 13 studies focusing on mechanisms of remote pre-or post-conditioning have revealed that K ATP channels also contribute to cardiac protection in remote ischemia conditioning (Loukogeorgakis et al. 2007 ). In addition, mitoK ATP channels play roles in cardiac protection of pre-conditioning and post-conditioning (Das and Sarkar 2005; Penna et al. 2006) . Thus, it is likely that opening of K ATP channels, especially mitoK ATP channels , serve as a common mechanism to prevent myocardium from I/R injury in variety of conditionings. Our study found that glibenclamide completely abolished the protective effect of RPerC in rats, suggesting that K ATP channels in sarcolemma or mitochondria membrane participate in cardiac protection of RPerC against I/R injury.
It is well known that enhanced bioavailability of endogenous nitric oxide (NO)
produced by the NO-synthases (NOS) mediates cardiac protection against I/R-induced injury. Both in vivo and in vitro studies have demonstrated that pharmacological inhibition of NO synthesis or genetic ablation of constitutive endothelial NOS (eNOS) exerts detrimental effects during myocardial infarction. On the other hand, NO donors or overexpression of eNOS or iNOS reduce myocardial injury (Jones et al. 2004; Jugdutt 2002; Kanno et al. 2000; Xuan et al. 2007) . In this study, we found that the expression levels of eNOS and iNOS were increased in RPerC rats compared with control rats, suggesting that NO is involved in the cardiac protection produced by RPerC.
Previous studies have shown that opioid, PKC, mitoK ATP channels and NO in IPC or RIPC interact (Cohen and Downey 2015; Maslov et al. 2016) . Liu et al. reported that IPC is triggered by receptor occupancy (Liu et al. 1991) . Schultz et al. reported that opioid, an endogenously released substances during I/R, binds to its receptors (Gprotein-coupled receptor) and the second messenger G i protein is cleaved into active α and βγ subunits which then results in activation of PKC (Schultz et al. D r a f t 14 1995). After being activated and translocated to the cell membrane, PKC phosphorylates multiple intracellular substrates and leads to the opening of the mitoK ATP channels (Downey et al. 2007; Schulz et al. 2001) . The opening of mitoK ATP channel is a critical step in cardiac protection signaling cascade. Opening of mitoK ATP blocks the mitochondrial permeability transition pore (MPTP) and inhibits apoptosis (Costa and Garlid 2008) . IPC's end-effector appears to be the MPTP and the inhibition of MPTP is considered to be the final step in the protective signal transduction pathway of pre-conditioning (Di Lisa et al. 2001; Hausenloy et al. 2002) .
Recent studies have shown that PKCε translocation may be a downstream event of mitoK ATP channels (Wang et al. 2015) . It is possible that there is feedback regulation between PKC and mitoK ATP channels. Studies on cardiac protection induced by IPC showed that activation of PKC leads to the opening of the mitoK ATP channels which triggers the modest ROS formation and then activates PKC (Downey et al. 2007) . NO is an important biological regulator and cellular signaling molecule. The eNOS has been implicated in the preconditioning pathways between Gi/o-coupled receptors and PKC (Maslov et al. 2016) . Thus, we propose that opioid produced during ischemia in RPerC may activate NOS, PKC, and mitoK ATP channels and inhibit MPTP to produce cardiac protection. The blockade of any elementsin this signaling pathway may result in a loss of cardiac protection.
In summary, this study demonstrated for the first time that RPerC protects heart against I/R injury through activation opioid receptor system and NO-PKC-mitoK ATP channel signaling pathways. maximal rate of rise of left ventricular systolic pressure; dp/dt min : maximal rate of decline of left ventricular systolic pressure; CON: control group; Pre-C:
pre-conditioning group; Per-C: per-conditioning group; Nal: naloxone group; Gli: glibeclamide group. per-conditioning group; Nal: Naloxone group; Gli: glibeclamide group. 
